Results 41 to 50 of about 148,376 (307)

Renal Amyloidosis Associated With 5 Novel Variants in the Fibrinogen A Alpha Chain Protein

open access: yesKidney International Reports, 2017
Fibrinogen A alpha chain amyloidosis is an autosomal dominant disease associated with mutations in the fibrinogen A alpha chain (FGA) gene, and it is the most common cause of hereditary renal amyloidosis in the UK.
Dorota Rowczenio   +18 more
doaj   +1 more source

Amyloidosis

open access: yesScandinavian Journal of Rheumatology, 1988
Recent studies have provided new insight into the pathogenesis of amyloidosis and have broadened our knowledge of the mechanisms of deposition and resolution of amyloid. In particular, the structure, synthesis and plasma clearance of the inflammation-associated amyloid precursor, SAA, have been extensively studied and the precursor-product relationship
openaire   +5 more sources

Avian amyloidosis [PDF]

open access: yesAvian Pathology, 1998
Although amyloid deposits have been described for more than a century and a half, its proteinaceous and fibrillar nature was not revealed until after 1950. Biochemical characterization of amyloids has brought to light that several non-related proteins can re-organize into amyloid fibrils. In some domestic and caged wild birds, and especially waterfowl,
Landman, W.J.M.   +2 more
openaire   +3 more sources

Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy

open access: yesJournal of Neurology, 2020
Amyloid transthyretin (ATTR) amyloidosis with polyneuropathy (PN) is a progressive, debilitating, systemic disease wherein transthyretin protein misfolds to form amyloid, which is deposited in the endoneurium. ATTR amyloidosis with PN is the most serious
D. Adams   +9 more
semanticscholar   +1 more source

Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group

open access: yesAmyloid: Journal of Protein Folding Disorders, 2022
Background This guideline has been developed jointly by the European Society of Haematology and International Society of Amyloidosis recommending non-transplant chemotherapy treatment for patients with AL amyloidosis.
A. Wechalekar   +11 more
semanticscholar   +1 more source

Systemic amyloidosis from A (AA) to T (ATTR): a review

open access: yesJournal of Internal Medicine, 2020
Systemic amyloidosis is a rare protein misfolding and deposition disorder leading to progressive organ failure. There are over 15 types of systemic amyloidosis, each caused by a different precursor protein which promotes amyloid formation and tissue ...
Eli Muchtar   +11 more
semanticscholar   +1 more source

Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis.

open access: yesCirculation Research, 2021
Often considered a rare disease, cardiac amyloidosis is increasingly recognized by practicing clinicians. The increased rate of diagnosis is in part due the aging of the population and increasing incidence and prevalence of cardiac amyloidosis with ...
J. Griffin, H. Rosenblum, M. Maurer
semanticscholar   +1 more source

Laryngeal amyloidosis [PDF]

open access: yesThe Laryngoscope, 1985
AbstractLocalized laryngeal amyloidosis is a benign, rare tumor of the larynx. Six cases of laryngeal amyloidosis were evaluated and treated from 1967 through 1984. One case is that of an 8‐year‐old female: the youngest reported case. Therapy is directed towards surgical resection.
M, Mitrani, H F, Biller
openaire   +2 more sources

A retrospective study of isatuximab-pomalidomide-dexamethasone in relapsed/refractory systemic AL amyloidosis

open access: yesHaematologica
Not available.
Sargam Rachit Vohra   +11 more
doaj   +1 more source

Dissecting the Molecular Features of Systemic Light Chain (AL) Amyloidosis: Contributions from Proteomics

open access: yesMedicina, 2021
Amyloidoses are characterized by aggregation of proteins into highly ordered amyloid fibrils, which deposit in the extracellular space of tissues, leading to organ dysfunction.
Paola Rognoni   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy